SPL 3.09% 10.0¢ starpharma holdings limited

India, Mundipharma production capacity

  1. 4,918 Posts.
    lightbulb Created with Sketch. 283
    It makes sense that if Starpharma make a move into India with Viraleze they would look to their current partner Mundipharma who already produce cold defense nasal spray. Bottle looks just same as Viralese so they have manufacturing capacity somewhere maybe even in India, I expect that an announcement re India could pop up at any given moment for sure CEO did not mention on tv news unless she had plans, exciting times imo.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
10.0¢
Change
0.003(3.09%)
Mkt cap ! $41.73M
Open High Low Value Volume
9.9¢ 10.5¢ 9.9¢ $12.72K 127.5K

Buyers (Bids)

No. Vol. Price($)
2 50204 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 69981 3
View Market Depth
Last trade - 10.43am 18/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.